Consumers for Paper Options (CPO), a coalition of individuals and organizations advocating for access to paper-based services and information, last week submitted comments urging the U.S. Food and Drug Administration (FDA) to maintain paper-format prescribing information for medications. Under a new proposed rule, prescription drugs would no longer include paper "professional inserts," which contain important prescribing information-such as drug interactions and dosing guidelines-used by pharmacists.
Consumers for Paper Options Urges FDA to Rescind Switch to Electronic Drug Labeling
Consumers for Paper Options (CPO), a coalition of individuals and organizations advocating for access to paper-based services and information, last week submitted comments urging the U.S. Food and Drug Administration (FDA) to maintain paper-format prescribing information for medications. Under a new proposed rule, prescription drugs would no longer include paper "professional inserts," which contain important prescribing information-such as drug interactions and dosing guidelines-used by pharmacists.